InvestorsHub Logo
Followers 113
Posts 11900
Boards Moderated 0
Alias Born 07/10/2014

Re: None

Thursday, 07/21/2022 1:09:45 PM

Thursday, July 21, 2022 1:09:45 PM

Post# of 724272
Another Phase 3 failure, now from Roche that they flopped their PD-1 Tecentriq even at kidney cancer. These clown should cut a deal with NWBO, imo.

https://endpts.com/roche-trims-out-some-pipeline-failures-while-flagging-a-phiii-flop-for-tecentriq/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News